Company news

ADC Therapeutics SA news in 2026

ADC Therapeutics SA's news releases, calls and decks from 2026, newest first.

View company

ADC Therapeutics Announces Abstracts at the 68th ASH Annual Meeting Highlighting Breadth of ZYNLONTA® Clinical Program

November 4, 2026

ADC Therapeutics to Present at November Investor Conferences

November 3, 2026

ADC Therapeutics Announces New Employee Inducement Grant

November 2, 2026

ADC Therapeutics Announces ZYNLONTA® Updates in Japan

October 29, 2026

ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements

October 8, 2026

ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

September 3, 2026

ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates

August 13, 2026

ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026

August 6, 2026

ADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination Trial

June 30, 2026

ADC Therapeutics Announces Strategic Reorganization to Support ZYNLONTA® Growth Opportunities and Regulatory Priorities

June 24, 2026

ADC Therapeutics Announces Results From LOTIS-5 Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

June 3, 2026

ADC Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Updates

May 4, 2026

ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026

April 27, 2026

ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update

March 10, 2026

ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026

March 3, 2026

ADC Therapeutics to Participate in March Investor Conferences

February 24, 2026

ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement

February 23, 2026

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

February 2, 2026

ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates

January 8, 2026

ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

January 8, 2026

ADC Therapeutics Announces New Employee Inducement Grant

January 2, 2026

Calls in 2026

Decks in 2026